Skip to main content

. 1982 Jan 30;284(6312):310–311. doi: 10.1136/bmj.284.6312.310

Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.

S Miyazaki, K Miura, Y Kasai, K Abe, K Yoshinaga

PMCID: PMC1495917 PMID: 6174171

310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Carretero O. A., Miyazaki S., Scicli A. G. Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension. 1981 Jan-Feb;3(1):18–22. doi: 10.1161/01.hyp.3.1.18. [DOI] [PubMed] [Google Scholar]
Lopez-Ovejero J. A., Saal S. D., D'Angelo W. A., Cheigh J. S., Stenzel K. H., Laragh J. H. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med. 1979 Jun 21;300(25):1417–1419. doi: 10.1056/NEJM197906213002505. [DOI] [PubMed] [Google Scholar]
Muramatu M., Fujii S. Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. Biochim Biophys Acta. 1972 Apr 7;268(1):221–224. doi: 10.1016/0005-2744(72)90218-5. [DOI] [PubMed] [Google Scholar]
Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977 Apr 22;196(4288):441–444. doi: 10.1126/science.191908. [DOI] [PubMed] [Google Scholar]
Overlack A., Stumpe K. O., Kühnert M., Kolloch R., Ressel C., Heck I., Krück F. Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition. Klin Wochenschr. 1981 Jan 15;59(2):69–74. doi: 10.1007/BF01477285. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES